The use of BIAsp 30 monotherapy or in combination with OADs in clinical practice was effective and safe in patients with poorly controlled type 2 diabetes mellitus.

In this observational study, in the type 2 diabetes mellitus patients who were poorly controlled on BHI, glycaemia improved when transferred to BIAsp30, and a lower incidence or rate of hypoglycaemia was observed in these patients.

Background: Overt hypothyroidism is associated with Insulin resistance (IR), accelerated arteriosclerosis and cardiovascular disease (CVD). Although SCH (SCH) is also associated with CVD risk remains controversial. Objective: The present research aimed to assess risk factors for CVD and IR in SCH cases. Methods: Case control study was carried out on 90 participants. The research included two groups; group one included 45 SCH cases and group two (controls) included 45 healthy volunteers. We assessed common lipid variables, fasting blood glucose, fasting insulin, HOMA IR, thyroid profile for all participants. Results: There was highly significant rise in anthropometric measures including body weight, BMI and waist circumference in SCH than controls (P value = <0.001). There was significant rise in systolic and diastolic blood pressure (BP) in SCH than controls (P value = <0.001, 0.001). There was significant rise in triglyceride level, total cholesterol and LDL-C in SCH in comparison to controls (P value = 0.019, <0.001, <0.001) and significant decline in HDL-C in SCH in comparison to controls (P value = 0.011). There was significant positive correlation between TSH level and anthropometric measures, BP, indices of IR, total cholesterol, triglycerides and LDL-C, but significant negative correlation with HDL-C. Conclusion: Our findings suggest that SCH might increase the risk for CVD which explain the needs for early detection and treatment of such individuals.

Background: Fibroscan has recently been investigated as a new technique in the assessment of fibrosis of the liver in many diseases.

Background:Recently, it has been demonstrated that anemia may be an etiological factor in development of microvascular complication in type 2 D.M. patients.Objective: Evaluation of the relation between anemia and microvascular complications in patients with type 2 diabetes mellitus.